Monitor for any future increase above 5%, which would require a Schedule 13D filing and could signal a shift to activist intent. The current sub-5% position suggests the fund is deliberately avoiding that threshold.
Price Chart
Executive Summary
AdvisorShares Trust filed an amended Schedule 13G disclosing a 4.95% passive stake in Quantum Biopharma Ltd. as of September 30, 2026, holding 400,378 Class B Subordinate Voting Shares. The filing indicates no change in the fund's passive intent, but the stake is just below the 5% threshold, suggesting a deliberate cap to avoid triggering a 13D filing.
Key Financial Metrics
Key Facts
- AdvisorShares Trust holds 400,378 Class B Subordinate Voting Shares of Quantum Biopharma Ltd.
- Stake represents 4.95% of the outstanding shares, just under the 5% reporting threshold.
- Filing is an amendment to a prior Schedule 13G, confirming passive investment intent.
- No change in ownership amount or percentage is indicated compared to the prior filing.
Financial Impact
No financial impact — stake is unchanged and remains passive.
Risk Factors
- If AdvisorShares Trust converts to a 13D filer, it could signal activist pressure on the company.
- A decrease in the stake below 4.95% would indicate reduced conviction.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000929638-26-003843 |
| Document: 0000929638-26-003843-index.html | 0000929638-26-003843 |
| Document: 0000929638-26-003843.txt | 0000929638-26-003843 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 6-K | $3.11 | awaiting T+20 | — | $2.21 (−28.94%) |
Oct 6, 2026 21d ago | 6-K | $3.09 | awaiting T+20 | — | $2.21 (−28.48%) |
Oct 6, 2026 21d ago | Press Release | $3.09 | awaiting T+20 | — | $2.21 (−28.48%) |
Oct 5, 2026 21d ago | SC 13G/A | $3.27 | awaiting T+20 | — | $2.21 (−32.42%) |
Sep 24, 2026 4w ago | 6-K | $4.00 $2.27 | ▼ −43.25% | ▼ −42.83% | $2.21 (−44.75%) |
Sep 17, 2026 5w ago | 6-K | $3.72 $2.71 | ▼ −27.15% | ▼ −28.36% | $2.21 (−40.59%) |
Sep 17, 2026 5w ago | 6-K | $3.72 $2.71 | ▼ −27.15% | ▼ −28.36% | $2.21 (−40.59%) |
Sep 15, 2026 5w ago | 6-K | $3.46 $2.89 | ▼ −16.47% | ▼ −19.45% | $2.21 (−36.13%) |
Sep 1, 2026 7w ago | 6-K | $3.08 $3.60 | ▲ +16.88% | ▲ +17.21% | $2.21 (−28.25%) |
Sep 1, 2026 7w ago | Press Release | $3.08 $3.60 | ▲ +16.88% | ▲ +17.21% | $2.21 (−28.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers